Collectively, these results demonstrated that in a subcutaneously implanted xenograft mouse model, olaparib effectively suppressed the growth of pancreatic cancer cells following Topbp1 knockdown in Patu8988 cells characterized by high Topbp1 expression. Here, TOPBP1 is linked to familial pancreatic carcinoma.